Condition: Stroke · PFO - Patent Foramen Ovale · Sponsor: W.L.Gore & Associates
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
This description comes directly from the study's public registry record.
Tammy DeLozier · 800-437-8181 · GSO1801@wlgore.com
Always discuss trial participation with your own doctor first.
| St. Mary's Hospital | Tucson, Arizona, United States | Withdrawn |
| Scripps Health La Jolla | La Jolla, California, United States | Recruiting |
| Loma Linda University Health | Loma Linda, California, United States | Recruiting |
| University of California - San Francisco | San Francisco, California, United States | Recruiting |
| Santa Barbara Cottage Hospital | Santa Barbara, California, United States | Recruiting |
| South Denver Cardiology Associates | Littleton, Colorado, United States | Recruiting |
| Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| Yale University School of Medicine | New Haven, Connecticut, United States | Recruiting |
| Baptist Health Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Naples Community Hospital | Naples, Florida, United States | Recruiting |
| University of SF (Tampa General Hospital) | Tampa, Florida, United States | Recruiting |
| Cleveland Clinic Florida | Weston, Florida, United States | Active Not Recruiting |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03821129